Correlation Between Immix Biopharma and Qualigen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Qualigen Therapeutics, you can compare the effects of market volatilities on Immix Biopharma and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Qualigen Therapeutics.
Diversification Opportunities for Immix Biopharma and Qualigen Therapeutics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Immix and Qualigen is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Qualigen Therapeutics go up and down completely randomly.
Pair Corralation between Immix Biopharma and Qualigen Therapeutics
Given the investment horizon of 90 days Immix Biopharma is expected to generate 1.05 times more return on investment than Qualigen Therapeutics. However, Immix Biopharma is 1.05 times more volatile than Qualigen Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 159.00 in Immix Biopharma on November 1, 2024 and sell it today you would earn a total of 40.00 from holding Immix Biopharma or generate 25.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. Qualigen Therapeutics
Performance |
| Timeline |
| Immix Biopharma |
| Qualigen Therapeutics |
Immix Biopharma and Qualigen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Qualigen Therapeutics
The main advantage of trading using opposite Immix Biopharma and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |